Free Delivery Over $100
|
|
|||
|
||||
OverviewThe National Institutes of Health Women's Health Initiative (WHI) is the largest research study ever funded by NIH ($625 million over 14 years) and is designed to test strategies to prevent cardiovascular disease, breast cancer, and osteoporotic fractures—leading causes of death, disability, and decreased quality of life for older women. Although the WHI has already begun, serious questions remain about its design, cost, and the likelihood that it can answer the questions it asks. This book evaluates whether the effort can be justified scientifically. Table of Contents Front Matter Executive Summary Introduction Clinical Trial Observational Study Community Prevention Study Concluding Remarks References Appendix A: Clinical Trial Exclusion Criteria Appendix B: U.S. House of Representatives Appropriations COmmittee Appendix C: Statement of Task Appendix D: Documents Received by the Institute of Medicine from the National Institutes of Health Appendix E: Meeting Participants June, July, and August 1993 Appendix F: Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial Appendix G: Women's Health Initiative Committees Appendix H: NIH-Sponsored Women's Health Studies Appendix I: NIH Cost and FTE Summary for Vanguard Clinical Centers Appendix J: NIH Power Calculations Appendix K: Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators Appendix L: Abbreviations and Acronyms Appendix M: Committee and Staff Biographies Full Product DetailsAuthor: Institute of Medicine , Committee to Review the NIH Women's Health Initiative , Dana Hotra , Susan ThaulPublisher: National Academies Press Imprint: National Academies Press Dimensions: Width: 21.60cm , Height: 1.30cm , Length: 27.90cm Weight: 0.454kg ISBN: 9780309049894ISBN 10: 030904989 Pages: 160 Publication Date: 01 February 1993 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Out of stock  The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of Contents1 Front Matter; 2 Executive Summary; 3 Introduction; 4 Clinical Trial; 5 Observational Study; 6 Community Prevention Study; 7 Concluding Remarks; 8 References; 9 Appendix A: Clinical Trial Exclusion Criteria; 10 Appendix B: U.S. House of Representatives Appropriations COmmittee; 11 Appendix C: Statement of Task; 12 Appendix D: Documents Received by the Institute of Medicine from the National Institutes of Health; 13 Appendix E: Meeting Participants June, July, and August 1993; 14 Appendix F: Primary and Subsidiary Hypotheses of the Women's Health Initiative Clinical Trial; 15 Appendix G: Women's Health Initiative Committees; 16 Appendix H: NIH-Sponsored Women's Health Studies; 17 Appendix I: NIH Cost and FTE Summary for Vanguard Clinical Centers; 18 Appendix J: NIH Power Calculations; 19 Appendix K: Women's Health Initiative Clinical Coordinating Center and Vanguard Clinical Centers Principal Investigators; 20 Appendix L: Abbreviations and Acronyms; 21 Appendix M: Committee and Staff BiographiesReviewsAuthor InformationSusan Thaul and Dana Hotra, Editors; Committee to Review the NIH Women's Health Initiative, Institute of Medicine Tab Content 6Author Website:Countries AvailableAll regions |
||||
